Ildong Holdings (000230) Fair Value & Analysis
Healthcare · KR · Market cap 81.5B KRW
Fair value as of: Jul 21, 2026
From 26 valuation models · updated today
Fair value updated Jul 21, 2026, revised from 21,286 KRW to 16,448 KRW (−22.7%) since Jun 25, 2026. Share price −14.4% over the past month.
Price vs Fair Value (12 months)
12‑month range 5,710 KRW – 15,660 KRW · fair‑value band 12,336 KRW – 20,560 KRW · the 5,810 KRW price screens below the 16,448 KRW fair value. As of Jul 21, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Ildong Holdings (000230) currently trades at 5,810 KRW, while our model-based Fair Value estimate is 16,448 KRW, implying the stock looks roughly 183.1% undervalued today. We read business quality at 36/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Ildong Holdings generated revenue of 599B KRW at a net margin of 2.9%. Revenue grew 5.5% year over year. It earns a return on equity of 10.1%. Net debt stands at 117B KRW. Fundamentals as of Jul 21, 2026
Our scenario range runs from 12,336 KRW (bear case) to 20,560 KRW (bull case); at 5,810 KRW, the current price sits below that range. The share trades about 66% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -49% fair-value upside, at 183%, 000230 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 21, 2026. TTM = trailing twelve months.
About the company
Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics. In addition, the company distributes medical devices, quasi drugs, health supplements, food products, beverages, cosmetics, sanitary ware, and other healthcare products through online; and manufactures original and generic prescription drugs. Further, it offers probiotics; pharmaceutical SI consulting, system development and deployment, RFID and barcode systems, and other solutions; and engages in advertising business. The company was formerly known as …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Ildong Holdings reported revenue of 591B KRW in FY2025 versus 592B KRW in FY2021, a compound −0.1%/yr. Reported net income was 10.9B KRW in FY2025.
Is 000230 fairly valued? → Check now
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥49.36 | ¥30.99 | -37% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,782 | ₹915.92 | -49% |
| Hansoh Pharmaceutical Group 3692 | HK$29.58 | HK$18.75 | -37% |
| Divi's Laboratories Limited DIVISLAB | ₹6,639 | ₹1,281 | -81% |
| Torrent Pharmaceuticals Limited TORNTPHARM | ₹4,421 | ₹1,504 | -66% |
| PharmaEssentia Corporation 6446 | 1,095 TWD | 365.87 TWD | -67% |
| Cipla Limited CIPLA | ₹1,401 | ₹592.37 | -58% |
| Zydus Lifesciences Limited ZYDUSLIFE | ₹1,089 | ₹841.98 | -23% |
| Lupin Limited LUPIN | ₹2,268 | ₹2,697 | +19% |
| Mankind Pharma Limited MANKIND | ₹2,336 | ₹1,068 | -54% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Ildong Holdings (000230) undervalued?
What is the fair value of 000230?
What is the quality score of 000230?
What is the revenue of Ildong Holdings (000230)?
What is the net profit margin of 000230?
Does Ildong Holdings pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Tell me when Ildong Holdings reaches its Fair Value
Just your email, and we'll notify you when the price and Fair Value of Ildong Holdings materially change. Free bonus: the monthly Top-25 report of the most undervalued quality stocks.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.